Headquartered in Brandon, FL, privately-held Jointechlabs is an emerging worldwide leader in regenerative medicine.
The company enables healthcare practitioners to provide safe, cost-effective, non-surgical therapies at the point-of-care without change in infrastructure.
FDA-cleared MiniTC® is a stand-alone device for processing autologous fat into regenerative-cell-rich microfat. Microfat’s uses include a variety of orthopedic, aesthetic, wound healing, and reconstructive surgery applications. Additionally, in certain markets, CE-Mark-approved Mini-Stem System® extracts microfat and Stromal Vascular Fraction. Pipeline includes development of stem-cell based therapeutics with 3D Bioprinted constructs and injectable stem cell scaffolding.
Posts attributed to Jointechlabs may have been written by one or more staff members, consultants, or third parties.
More Information: https://www.jointechlabs.com.
Home Page: https://jointechlabs.com
Gloria Sue, Dung Nguyen, Dimitris Dionysiou, Tatiana Zaitseva, Cristhian Montenegro, Peter Tabada, Peter Deptula, Derrick Wan, Nathan Katz, Michael Paukshto, Stanley Rockson. Stanford University, Stanford, CA, US Aristotle University of Thessaloniki, Greece Fibralign Corp, Union City, CA, US Jointechlabs, San Francisco, CA, US To address the current deficit of sustainable lymphedema treatment, we investigated lymphatic […]
Nathan Katz, MSc, Ph.D., Jointechlabs, Inc., USAAvner Yayun, MD, Ph.D., Procore Biomed, Israel Procore Biomed has developed a hyaluronic-acid – plasma cross-linked hydrogel “RegenoGel” suitable for the growth and differentiation of skeletal tissue stem and progenitor cells. Jointechlabs has provided adipose-derived cell fraction obtained by the “Mini-Stem System”, which contains a range of 2-8% of […]
Treating patients with OA presents a significant challenge for physicians as no therapies to date have demonstrated efficacy in curing or even halting disease progression. Therefore, most approaches initially target pain management and factors that may be exacerbating stress on the joint. https://dx.doi.org/10.2147%2FSCCAA.S68073 – Mayo Clinic, MN Corticosteroid toxicity for chondrocytes has been long reported, both […]
Katz, N., Koukharenko, V. and Geldner, P2,3. Laboratory of Stem cells and Bioengineering, Jointechlabs, Inc., Skokie, IL North Michigan Surgical Center, Chicago, IL Geldner Center, Chicago, IL Introduction: Fat auto graft transplantation method for different reconstructive plastic surgeries has been fueled recently by encouraging reports from Japan, the United Kingdom, the United States, and others. […]
Jointechlabs Launches MiniTC for Point-of-Care Fat Tissue Processing The scientific community has regarded regeneration as a topic of interest for thousands of years. Long before it was dubbed ‘Regenerative Medicine’, this type of medical intervention was applauded by healthcare professionals for its successful outcomes. Early discoveries, such as skin graft procedures for facial reconstructions, have […]
Jointechlabs – a leader in point-of-care regenerative medicine therapies – today announced that the U.S. Food and Drug Administration (FDA) cleared the company’s MiniTCTM for point-of-care fat tissue processing designed to obtain microfat (or fat grafts), for multiple indications. Jointechlabs plans to focus on a range of therapeutic areas including medical aesthetics, plastic surgery, orthobiologics […]